Endometrial cancer is the most common gynecological malignancy after breast cancer in developed countries. Its incidence is steadily rising and, now, the lifetime risk of developing endometrial cancer in the industrialized areas is about 23%. This book deals with the main aspects of disease management, including the perspectives for primary and secondary prevention, and the most recent interpretation of its pathogenesis. The management of endometrial cancer continues to evolve as we better understand tumour biology and more widely apply what evidence-based medicine comes from. This book may be of interest and a useful update for any health provider involved in gynaecological cancer care.